Leodizcol

Baclofen, the active ingredient in Leodizcol, is a muscle relaxant presented as an oral tablet for oral use. It is employed to treat spasticity and muscle spasm in patients with neurological conditions that cause increased muscle tone. Baclofen works by modulating spinal reflexes and reducing excitatory neurotransmitter release, thereby lowering muscle stiffness.

GNH USA supplies Leodizcol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Leodizcol (baclofen) acts on the central nervous system to alleviate abnormal muscle tone associated with several neurological disorders.

- Spasticity (multiple sclerosis): Decreases muscle stiffness and improves functional mobility. - Spasticity (spinal cord injury): Reduces involuntary muscle contractions and facilitates rehabilitation. - Muscle spasm (acute): Relieves painful muscle tightening and enhances comfort.

Leodizcol may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Drowsiness: Feeling unusually sleepy or fatigued. - Dizziness: Light‑headed sensation, especially when standing quickly. - Weakness: Reduced muscular strength or endurance. - Nausea: Upset stomach or urge to vomit. - Constipation: Infrequent or difficult bowel movements. - Headache: Mild to moderate head pain.

Serious or Rare Side Effects: - Seizures: Uncontrolled convulsive episodes. - Hallucinations: Visual or auditory disturbances. - Respiratory depression: Slowed breathing that may require medical attention. - Severe hypotension: Marked drop in blood pressure causing faintness. - Allergic reactions: Rash, itching, swelling, or anaphylaxis.

Before prescribing Leodizcol, clinicians should consider several safety factors.

- Renal impairment: Monitor renal function and adjust therapy as needed. - Hepatic disease: Use with caution; liver dysfunction may alter drug metabolism. - Concomitant CNS depressants: Assess risk of enhanced sedation or respiratory depression. - Abrupt discontinuation: Taper the dose gradually to avoid withdrawal symptoms. - Pregnancy and lactation: Safety data are limited; evaluate risk‑benefit ratio. - Store at ambient temperature: Keep below 25°C in the original packaging, protected from moisture.

Baclofen can interact with other medications, influencing its efficacy and safety profile.

Major Interactions (Avoid): - Alcohol: Potentiates central nervous system depression. - Opioids: Increases risk of profound sedation and respiratory depression. - Other muscle relaxants: May cause additive hypotonia.

Moderate Interactions (Monitor Closely): - CYP450 inhibitors (e.g., ciprofloxacin): May raise baclofen plasma levels. - Antihypertensives: Potential for additive blood pressure lowering. - Antiepileptic drugs: May alter seizure threshold.